HEART FAILURE by Nancy Jenkins

1. HEART FAILUREby Nancy Jenkins • The most common reason for hospitalization in adults >65 years old.

3. Heart Failure Cardiogenic shock Cardiomyopathy Uncompensated Heart Failure Pulmonary Edema-ADHF Severe End Stage Mild Mild Control With /Same as Mild with Morphine Sulfate Irreversible Needs new ventricle VAD IABP Drugs Diet Fluid Restriction VAD IABP Heart Transplant

4. Heart Failure Pneumonic U Upright Position N Nitrates L Lasix O Oxygen A Amiodorone, ACE, ARBs D Dig, Dobutamine M Morphine Sulfate E Extremities Up or Down

5. Definition • CO=SVxHR is insufficient to meet the metabolic needs of the body • SV is determined by preload, afterload and myocardial contractility • Systolic failure- dec. contractility • Diastolic failure- dec. filling • EF< 40%

6. Heart FailureEtiology and Pathophysiology • Systolic failure is the most common cause • Hallmark finding: Decrease in the left ventricular ejection fraction (EF) • Caused by • Impaired contractile function (e.g., MI) • Increased afterload (e.g., hypertension) • Cardiomyopathy • Mechanical abnormalities (e.g., valve disease) http://coursewareobjects.elsevier.com/objects/mccance5e_v1/McCance/Module15/Part02/M15L04S41a.html??hostType=undefined&authorName=Mccance&prodType=undefined

7. Systolic Failure hypokinesis

8. 90/140= 64% EF- 55-65 normal

9. Heart FailureEtiology and Pathophysiology • Diastolic failure • Impaired ability of the ventricles to relax and fill during diastole resulting in decreased stroke volume and CO • Diagnosis based on the presence of pulmonary congestion, pulmonary hypertension, ventricular hypertrophy, normal ejection fraction (EF) diastolic failure

10. Heart FailureEtiology and Pathophysiology • Mixed systolic and diastolic failure • Seen in disease states such as dilated cardiomyopathy (DCM) • Poor EFs (<35%) • High pulmonary pressures • Biventricular failure (both ventricles may be dilated and have poor filling and emptying capacity)

11. Your patient has a normal EF but shows signs of heart failure. Your patient most likely has: • Decreased cardiac output • Systolic failure • Diastolic failure • LV hyypertrophy

12. Preload • Volume of blood in ventricles at end diastole. • Depends on venous return • Depends on compliance

13. The administration of lasix IV helps increase preload. • True • False

14. Afterload • Force needed to eject the blood into the circulation • Arterial B/P, pulmonary artery pressure • Valvular disease increases afterload

17. CHF • Pathophysiology • A. Cardiac compensatory mechanisms • 1.tachycardia • 2.ventricular dilation-Starling’s law • 3.myocardial hypertrophy • Hypoxia leads to dec. contractility http://www.heartsite.CHF/html/chf_3.html

18. cont. • B.Homeostatic compensatory mechanisms- (medications block these) • Sympathetic Nervous System-(beta blockers block this) • 1.vascular system- norepinephrine- vasoconstriction(What effect on afterload?) (ACE) • 2.kidneys- • A. dec. CO and B/P cause renin angiotensin release.(ACE) • B. Aldosterone release causes Na and H2O retention(aldactone) • Inc. Na causes release of ADH(diuretics) • Release of atrial natriuretic factor- promotes Na and H20 excretion and prevents severe cardiac decompensation • 3.liver- stores venous volume(ascites, +HJR), • Hepatamegaly- can store 10 L. check enzymes

19. Heart FailureEtiology and Pathophysiology • Compensatory mechanisms are activated to maintain adequate CO • Neurohormonal responses: Endothelin is stimulated by ADH, catecholamines, and angiotensin II and causes • Arterial vasoconstriction • Increase in cardiac contractility • Hypertrophy

20. Heart FailureEtiology and Pathophysiology • Compensatory mechanisms are activated to maintain adequate CO • Neurohormonal responses: Proinflammatory cytokines (e.g., tumor necrosis factor) • Released by cardiac myocytes in response to cardiac injury • Depress cardiac function by causing cardiac hypertrophy, contractile dysfunction, and myocyte cell death

21. Heart FailureEtiology and Pathophysiology • Compensatory mechanisms are activated to maintain adequate CO • Neurohormonal responses: Over time, a systemic inflammatory response is mounted resulting in • Cardiac wasting • Muscle myopathy • Fatigue

22. Heart FailureEtiology and Pathophysiology • Counter regulatory processes • Natriuretic peptides: atrial natriuretic peptide (ANP) and b-type natriuretic peptide (BNP) • Released in response to increases in atrial volume and ventricular pressure • Promote venous and arterial vasodilation, reducing preload and afterload • Prolonged HF leads to a depletion of these factors

23. Which of the following are compensatory mechanisms for HF? • Tachycardia • Hypotension • RAAS • LV hypertrophy

24. Heart FailureEtiology and Pathophysiology • Counter regulatory processes • Natriuretic peptides are endothelin and aldosterone antagonists so they: • Enhance diuresis • Block effects of the RAAS • Natriuretic peptides inhibit the development of cardiac hypertrophy and may have antiinflammatory effects • **Natrecor or Neseritide has same effects

26. Result of Compensatory Mechanisms Heart Failure

27. PathophysiologyStructural Changes • Decreased contractility • Increased preload (volume) • Increased afterload (resistance) • Ventricular remodeling(ACE inhibitors can prevent this) • Ventricular hypertrophy • Ventricular dilation

28. Heart Failure- Hypertrophy

29. Ventricular remodeling(from football to basketball)

31. END RESULT FLUID OVERLOAD AND EDEMA

33. Heart FailureClassification Systems • New York Heart Association Functional Classification of HF • Classes I to IV • ACC/AHA Stages of HF • Stages A to D

34. AHA Newer Classifications of Heart Failure- Staging

35. Treating the Heart, Blood Vessels and Circulation Stage A • Those at high risk for developing heart failure. Includes people with: • Hypertension • Diabetes mellitus • Coronary artery disease (including heart attack) • History of cardiotoxic drug therapy • History of alcohol abuse • History of rheumatic fever • Family history of CMP • Exercise regularly • Quit smoking • Treat hypertension • Treat lipid disorders • Discourage alcohol or illicit drug use • If previous heart attack or current diabetes mellitus or hypertension ® angiotensin converting enzyme inhibitor (ACE-I) Stage B Those diagnosed with “systolic” heart failure but have never had symptoms of heart failure (usually by finding an ejection fraction of less than 40% on echocardiogram). • Care measures in Stage A + • All patients should be on ACE-I • Beta-blockers should be added • Surgical consultation for coronary artery revascularization and valve repair/replacement (as appropriate) Stage C • Patients with known heart failure with current or prior symptoms. • Symptoms include: • Shortness of breath • Fatigue • Reduced exercise intolerance. • In this group, care measures from Stage A apply, ACE-I and beta-blockers should be used + • Diuretics (water pills) • Digoxin • Dietary sodium (salt) restriction • Weight monitoring • Fluid restriction (as appropriate) • Withdrawal of drugs that worsen the condition • Spironolactone when symptoms remain severe with other therapies ©Cleveland Clinic Foundation Health Information Center, revised 4/02

36. Treating the Heart, Blood Vessels and Circulation : Usual Therapies Stage D Presence of advanced symptoms, after assuring optimized medical care • All therapies under Stages A, B and C + evaluation for: • Cardiac transplantation • Ventricular assist devices • Surgical options • Research therapies • Continuous intravenous inotropic infusions • End-of-life care

37. A patient has an EF of 15% and is a candidate for a heart transplant. Which AHA stage would he be considered to be? • Stage C • Stage A • Stage D • Stage B

38. Heart FailureEtiology and Pathophysiology • Primary risk factors • Coronary artery disease (CAD) • Advancing age • Contributing risk factors • Hypertension • Diabetes • Tobacco use • Obesity • High serum cholesterol • African American descent • Valvular heart disease • Hypervolemia

39. Which of the following are risk factors for Heart Failure • Hypertension • Myocardial Infarction • Diabetes • Valvular Disease

40. Classifications • Systolic versus diastolic • Systolic- loss of contractility get dec. CO • Diastolic- decreased filling or preload • Left-sided versus right –sided • Left- lungs • Right-peripheral • High output- hypermetabolic state- pregnancy • Acute versus chronic • Acute- MI • Chronic-cardiomyopathy

41. Symptoms

42. Left Ventricular Failure • Signs and symptoms • dyspnea • orthopnea PND • Cheyne Stokes • fatigue • Anxiety • rales • NOTE L FOR LEFT AND L FOR LUNGS

43. Which of the following is associated with left sided failure? • crackles • hypoxemia • tachypnea • Peripheral edema

44. ??????? • WHY DOES THIS OCCUR?

45. Heart FailureClinical Manifestations • Acute decompensated heart failure (ADHF) • Pulmonary edema, often life-threatening • Early • Increase in the respiratory rate • Decrease in PaO2 • Later • Tachypnea • Respiratory acidemia

46. Heart FailureClinical Manifestations • Acute decompensated heart failure (ADHF) • Physical findings • Orthopnea • Dyspnea, tachypnea • Use of accessory muscles • Cyanosis • Cool and clammy skin

47. Heart FailureClinical Manifestations • Acute decompensated heart failure (ADHF) • Physical findings • *Cough with frothy, blood-tinged sputum-why??? • Breath sounds: Crackles, wheezes, rhonchi • Tachycardia • Hypotension or hypertension

48. Case study of Heart Failure in Lewis online resources

49. Pulmonary Edema(advanced L side HF) • When PA WEDGE pressure is approx 30mmHg • Signs and symptoms • 1.wheezing • 2.pallor, cyanosis • 3.Inc. HR and BP • 4.s3 gallopThe Auscultation Assistant - Rubs and Gallops • 5.rales,copious pink, frothy sputum

50. An S3 or ventricular gallop is associated with heart failure. • True • False